Pinnacle Bancorp’s DexCom DXCM Stock Holding History

Pinnacle Bancorp’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-241	Closed	-$22.5K	–	808
2023 Q3	$22.5K	Hold	241	–	–	0.01%	496
2023 Q2	$31K	Hold	241	–	–	0.01%	446
2023 Q1	$28K	Hold	241	–	–	0.01%	450
2022 Q4	$27K	Hold	241	–	–	0.01%	430
2022 Q3	$19K	Sell	241 -47	-16%	-$3.98K	0.01%	460
2022 Q2	$21K	Hold	288	–	–	0.01%	439
2022 Q1	$37K	Hold	288	–	–	0.01%	384
2021 Q4	$39K	Hold	288	–	–	0.01%	384
2021 Q3	$39K	Sell	288 -244	-46%	-$30.8K	0.02%	378
2021 Q2	$57K	Hold	532	–	–	0.03%	329
2021 Q1	$48K	Hold	532	–	–	0.02%	353
2020 Q4	$49K	Hold	532	–	–	0.03%	322
2020 Q3	$55K	Hold	532	–	–	0.04%	292
2020 Q2	$54K	Hold	532	–	–	0.04%	284
2020 Q1	$36K	Hold	532	–	–	0.03%	297
2019 Q4	$29K	Sell	532 -132	-20%	-$6.26K	0.02%	380
2019 Q3	$25K	Buy	664 +132	+25%	+$5.13K	0.01%	414
2019 Q2	$20K	Hold	532	–	–	0.01%	437
2019 Q1	$16K	Hold	532	–	–	0.01%	461
2018 Q4	$16K	Buy	+532	New	+$16.9K	0.01%	459

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Pinnacle Bancorp's DXCM Position: Q4 2023 in Review

Pinnacle Bancorp sold out of DexCom (DXCM) in Q4 2023, closing a stake of 241 shares — an estimated $22.5K sold.

Pinnacle Bancorp first reported a position in DXCM in Q4 2018 and held it in 20 quarters. The position peaked at $57K in Q2 2021. 975 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

Pinnacle Bancorp reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
Pinnacle Bancorp sold 241 DexCom shares in Q4 2023, an estimated $22.5K.
Pinnacle Bancorp first reported a position in DexCom in Q4 2018 and held it in 20 quarters.
Pinnacle Bancorp's DexCom position peaked at $57K in Q2 2021.
975 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Pinnacle Bancorp's 13F filing for Q4 2023, filed 25 Jan 2024.